Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Breast Neoplasms 53Neoplasms 36Lung Neoplasms 24Colorectal Neoplasms 23Prostatic Neoplasms 17Uterine Cervical Neoplasms 14Motor Activity 13Colonic Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Rectal Neoplasms 9Anxiety Disorders 9Urinary Bladder Neoplasms 8Obesity 8Melanoma 8Depression 8Pancreatic Neoplasms 7Lymphoma 7Hematologic Neoplasms 7Endometrial Neoplasms 7Vulvar Neoplasms 6Ovarian Neoplasms 6Head and Neck Neoplasms 6Breast Carcinoma In Situ 6Sarcoma 5Pain 5Hematopoietic and Lymphatic System Neoplasm 5Triple Negative Breast Neoplasms 4Stomach Neoplasms 4Papillomavirus Infections 4Neoplasm Metastasis 4

Interventions

Low-Level Light Therapy 5Radiation 4Radiotherapy 3Propolis 3Morphine 3Methotrexate 3Leucovorin 3Cryotherapy 3Cisplatin 3glucarpidase 2Probiotics 2Pentoxifylline 2Mouthwashes 2Melphalan 2Ketamine 2Interleukin 1 Receptor Antagonist Protein 2Honey 2Glutamine 2Gabapentin 2Fluorouracil 2Fibroblast Growth Factor 7 2Drug Therapy 2Amifostine 2peppermint oil 1pegfilgrastim 1pegaspargase 1oxycodone-acetaminophen 1nelarabine 1maltodextrin 1kang-lai-te 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mucositis × Methods × Clear all
NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡